Zelin Liu

601 total citations
33 papers, 372 citations indexed

About

Zelin Liu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Zelin Liu has authored 33 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Genetics. Recurrent topics in Zelin Liu's work include CAR-T cell therapy research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer-related molecular mechanisms research (3 papers). Zelin Liu is often cited by papers focused on CAR-T cell therapy research (6 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer-related molecular mechanisms research (3 papers). Zelin Liu collaborates with scholars based in China, United States and Ghana. Zelin Liu's co-authors include Jixiong Xu, Jianying Liu, Wei Cai, Chunping Zhang, Ying Liu, Yunliang Tang, Shan Jiang, Jia Guo, Qinghua Wang and Fuxu Wang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zelin Liu

30 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zelin Liu China 9 153 90 77 55 47 33 372
Taichi Murakami Japan 13 234 1.5× 173 1.9× 71 0.9× 47 0.9× 83 1.8× 44 522
Yiyao Deng China 12 166 1.1× 184 2.0× 46 0.6× 31 0.6× 53 1.1× 20 436
Tatsuru Ota Japan 9 184 1.2× 193 2.1× 43 0.6× 69 1.3× 56 1.2× 16 438
Søren Krag Denmark 15 145 0.9× 127 1.4× 97 1.3× 63 1.1× 89 1.9× 26 480
Mengjie Jiang China 12 71 0.5× 66 0.7× 131 1.7× 85 1.5× 91 1.9× 35 381
Yanna Dou China 9 84 0.5× 134 1.5× 45 0.6× 29 0.5× 61 1.3× 25 326
Shinya Nagasaka Japan 14 136 0.9× 109 1.2× 37 0.5× 30 0.5× 85 1.8× 24 486
Hong Ren China 13 234 1.5× 224 2.5× 97 1.3× 87 1.6× 120 2.6× 37 692
M. L. Maestro Spain 13 123 0.8× 53 0.6× 171 2.2× 98 1.8× 85 1.8× 27 459

Countries citing papers authored by Zelin Liu

Since Specialization
Citations

This map shows the geographic impact of Zelin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelin Liu more than expected).

Fields of papers citing papers by Zelin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelin Liu. The network helps show where Zelin Liu may publish in the future.

Co-authorship network of co-authors of Zelin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zelin Liu. A scholar is included among the top collaborators of Zelin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelin Liu. Zelin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Yangyang, Zelin Liu, Ya Liao, et al.. (2025). CBX7 regulates chemotherapy-induced senescence-like growth arrest in multiple myeloma via the ERK/STAT3/PIM1 axis. Journal of Translational Medicine. 23(1). 1292–1292.
2.
Liu, Peiran, et al.. (2025). Global bone cancer incidence and death rate analysis at 40 years. Discover Oncology. 16(1). 1087–1087. 2 indexed citations
3.
Liu, Zelin, et al.. (2025). Comprehensive network pharmacology and experimental study to investigate the effects and mechanisms of Lophatherum gracile Brongn. for glioma treatment. Experimental Cell Research. 450(2). 114671–114671. 1 indexed citations
4.
Ding, Yangyang, Cheng Sun, Zelin Liu, et al.. (2024). A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma. Scientific Reports. 14(1). 21184–21184. 2 indexed citations
5.
6.
Liang, Xue, Linhui Hu, Yangyang Ding, et al.. (2024). Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies. Journal of Translational Medicine. 22(1). 613–613. 2 indexed citations
7.
Pu, Lianfang, Manman Li, Linhui Hu, et al.. (2024). Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma. Journal of Leukocyte Biology. 115(6). 1094–1107. 1 indexed citations
8.
Liu, Zelin, et al.. (2023). Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer. Experimental Cell Research. 429(2). 113686–113686. 2 indexed citations
9.
Liu, Zelin, et al.. (2023). SESN2 Could Be a Potential Marker for Diagnosis and Prognosis in Glioma. Genes. 14(3). 701–701. 5 indexed citations
10.
Liu, Zelin, et al.. (2022). SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway. Cancer Cell International. 22(1). 127–127. 15 indexed citations
11.
Liu, Zelin, Yuan‐Wu Chen, Yongqiang Ji, et al.. (2022). Levitt’s CO breath test in the differential diagnosis of chronic isolated hyperbilirubinemia. Journal of Breath Research. 16(2). 26007–26007. 2 indexed citations
12.
Chen, Yilin, Zelin Liu, Meng Li, et al.. (2022). Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China. Haematologica. 107(8). 1966–1970. 4 indexed citations
13.
Zhang, Liting, Hongmiao Yu, Haoxuan Du, et al.. (2021). TLR2 inhibition ameliorates the amplification effect of LPS on lipid accumulation and lipotoxicity in hepatic cells. Annals of Translational Medicine. 9(18). 1429–1429. 8 indexed citations
14.
Liu, Zelin & Hou‐De Zhang. (2020). Abnormally Short Erythrocyte LifeSpan in Three Patients with Primary Myelofibrosis Despite Successful Control of Splenomegaly. The American Journal of the Medical Sciences. 361(2). 274–277. 2 indexed citations
15.
Liu, Zelin, et al.. (2020). Gilbert’s syndrome coexisting with hereditary spherocytosis might not be rare: Six case reports. World Journal of Clinical Cases. 8(10). 2001–2008. 7 indexed citations
16.
Wang, Zhenyuan, et al.. (2018). Adaptive SVR Denoising Algorithm for Fetal Monitoring System. 1–5. 3 indexed citations
17.
Lü, Bo, et al.. (2017). [Effect of Metformin on Proliferation of Multiple Myeloma Cells].. PubMed. 25(4). 1097–1100. 4 indexed citations
18.
19.
Liu, Zelin. (2008). Venous Thrombosis in the Elderly. 1 indexed citations
20.
Liu, Zelin, et al.. (2004). [Mutation analysis of SHIP gene in acute leukemia].. PubMed. 25(7). 385–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taichi Murakami Breakdown of academic impact, for papers by Yiyao Deng Breakdown of academic impact, for papers by Tatsuru Ota Breakdown of academic impact, for papers by Søren Krag Breakdown of academic impact, for papers by Mengjie Jiang Breakdown of academic impact, for papers by Yanna Dou Breakdown of academic impact, for papers by Shinya Nagasaka Breakdown of academic impact, for papers by Hong Ren Breakdown of academic impact, for papers by M. L. Maestro
Rankless by CCL
2026